Scientific opinion on the regulation of gene-edited plant products within the context of Division 28 of the Food and Drug Regulations (Novel Foods) (English, HTML)

View metadata and access the original English HTML file: Scientific opinion on the regulation of gene-edited plant products within the context of Division 28 of the Food and Drug Regulations (Novel Foods).

Format

HTML

Access

file-only

Publisher-reported update

2022-12-02

Health Canada has developed its scientific opinion regarding the regulation of gene-edited plant products within the context of the Novel Food Regulations. This opinion helped to inform the development of the Department's new Health Canada Guidance on the Novelty Interpretation of Products of Plant Breeding and Health Canada Guidance on the Pre-Market Assessment of Foods Derived from Retransformants.

Access original file